These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30275179)
1. Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress. Okubo K; Isono M; Asano T; Sato A Anticancer Res; 2018 Oct; 38(10):5615-5626. PubMed ID: 30275179 [TBL] [Abstract][Full Text] [Related]
2. Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells. Sato A; Asano T; Isono M; Ito K; Asano T BMC Urol; 2014 Aug; 14():71. PubMed ID: 25176354 [TBL] [Abstract][Full Text] [Related]
3. Nelfinavir Induces Endoplasmic Reticulum Stress and Sensitizes Renal Cancer Cells to TRAIL. Okubo K; Sato A; Isono M; Asano T; Asano T Anticancer Res; 2018 Aug; 38(8):4505-4514. PubMed ID: 30061216 [TBL] [Abstract][Full Text] [Related]
4. Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically by Inducing Endoplasmic Reticulum Stress. Sato A; Asano T; Okubo K; Isono M; Asano T Oncol Res; 2018 Mar; 26(2):323-332. PubMed ID: 28560953 [TBL] [Abstract][Full Text] [Related]
5. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Gills JJ; Lopiccolo J; Tsurutani J; Shoemaker RH; Best CJ; Abu-Asab MS; Borojerdi J; Warfel NA; Gardner ER; Danish M; Hollander MC; Kawabata S; Tsokos M; Figg WD; Steeg PS; Dennis PA Clin Cancer Res; 2007 Sep; 13(17):5183-94. PubMed ID: 17785575 [TBL] [Abstract][Full Text] [Related]
6. Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells. Isono M; Sato A; Asano T; Okubo K; Asano T Anticancer Res; 2018 Jun; 38(6):3493-3500. PubMed ID: 29848702 [TBL] [Abstract][Full Text] [Related]
7. Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells. Okubo K; Isono M; Miyai K; Asano T; Sato A Cancer Sci; 2020 Jan; 111(1):112-126. PubMed ID: 31675763 [TBL] [Abstract][Full Text] [Related]
8. Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer Cells. Isono M; Sato A; Okubo K; Asano T; Asano T Oncol Res; 2016; 24(5):327-335. PubMed ID: 27712589 [TBL] [Abstract][Full Text] [Related]
9. Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells. Sato A; Asano T; Ito K; Asano T Urology; 2012 Apr; 79(4):966.e13-21. PubMed ID: 22296623 [TBL] [Abstract][Full Text] [Related]
10. Lopinavir-Ritonavir Combination Induces Endoplasmic Reticulum Stress and Kills Urological Cancer Cells. Okubo K; Isono M; Asano T; Sato A Anticancer Res; 2019 Nov; 39(11):5891-5901. PubMed ID: 31704813 [TBL] [Abstract][Full Text] [Related]
11. Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir. Abt D; Besse A; Sedlarikova L; Kraus M; Bader J; Silzle T; Vodinska M; Slaby O; Schmid HP; Engeler DS; Driessen C; Besse L BJU Int; 2018 Apr; 121(4):600-609. PubMed ID: 29161753 [TBL] [Abstract][Full Text] [Related]
12. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation. Brüning A; Rahmeh M; Friese K Mol Oncol; 2013 Dec; 7(6):1012-8. PubMed ID: 23916134 [TBL] [Abstract][Full Text] [Related]
13. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells. Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585 [TBL] [Abstract][Full Text] [Related]
14. The Dual Histone Deacetylase-Proteasome Inhibitor RTS-V5 Acts Synergistically With Ritonavir to Induce Endoplasmic Reticulum Stress in Bladder Cancer Cells. Okubo K; REßING N; Schulz WA; Hansen FK; Asano T; Sato A Anticancer Res; 2021 Dec; 41(12):5987-5996. PubMed ID: 34848452 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway. Han KS; Li N; Raven PA; Fazli L; Frees S; Ettinger S; Park KC; Hong SJ; Gleave ME; So AI Oncotarget; 2015 Oct; 6(33):34818-30. PubMed ID: 26472187 [TBL] [Abstract][Full Text] [Related]
16. The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo. Bono C; Karlin L; Harel S; Mouly E; Labaume S; Galicier L; Apcher S; Sauvageon H; Fermand JP; Bories JC; Arnulf B Haematologica; 2012 Jul; 97(7):1101-9. PubMed ID: 22271897 [TBL] [Abstract][Full Text] [Related]
17. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Rao R; Balusu R; Fiskus W; Mudunuru U; Venkannagari S; Chauhan L; Smith JE; Hembruff SL; Ha K; Atadja P; Bhalla KN Mol Cancer Ther; 2012 Apr; 11(4):973-83. PubMed ID: 22367781 [TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer. Wang G; Niu X; Zhang W; Caldwell JT; Edwards H; Chen W; Taub JW; Zhao L; Ge Y Cancer Lett; 2015 Jan; 356(2 Pt B):656-68. PubMed ID: 25458954 [TBL] [Abstract][Full Text] [Related]
19. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells. Wu WS; Chien CC; Chen YC; Chiu WT PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Pyrko P; Kardosh A; Wang W; Xiong W; Schönthal AH; Chen TC Cancer Res; 2007 Nov; 67(22):10920-8. PubMed ID: 18006837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]